<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id>
      <journal-id journal-id-type="publisher-id">rbti</journal-id>
      <journal-title-group>
        <journal-title>Revista Brasileira de Terapia Intensiva</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0103-507X</issn>
      <issn pub-type="epub">1982-4335</issn>
      <publisher>
        <publisher-name>Associa&#xE7;&#xE3;o de Medicina Intensiva Brasileira -
AMIB</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26761479</article-id>
      <article-id pub-id-type="pmc">4738827</article-id>
      <article-id pub-id-type="doi">10.5935/0103-507X.20150066</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Use of venoarterial extracorporeal membrane oxygenation in
fulminant chagasic myocarditis as a bridge to heart
transplant</article-title>
        <trans-title-group>
          <trans-title>Uso de membrana de oxigena&#xE7;&#xE3;o
extracorp&#xF3;rea venoarterial em um caso de miocardite
chag&#xE1;sica fulminante como ponte para transplante
card&#xED;aco</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dur&#xE3;es</surname>
            <given-names>Andr&#xE9; Rodrigues</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueira</surname>
            <given-names>Fernando Augusto Marinho dos Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lafayette</surname>
            <given-names>Andr&#xE9; Rabelo</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martins</surname>
            <given-names>Juliana de Castro Solano</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Juliano Cavalcante de</surname>
            <given-names>S&#xE1;</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Universidade do Estado da Bahia - Salvador (BA),
Brazil.</aff>
      <aff id="aff2"><label>2</label>Instituto de Medicina Integral Professor Fernando
Figueira - Recife (PE), Brazil.</aff>
      <author-notes>
        <corresp id="c1"><bold>Corresponding author:</bold> Andre Rodrigues Duraes, Hospital Ana
Nery, Rua Saldanha Marinho - Caixa D'&#xE1;gua, Zip code: 40320-010 -
Salvador (BA), Brazil. E-mail: <email>andreduraes@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Oct-Dec</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>27</volume>
      <issue>4</issue>
      <fpage>397</fpage>
      <lpage>401</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an Open Access article distributed under the terms of
the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 17-year-old Brazilian male presented with progressive dyspnea for 15 days,
worsening in the last 24 hours, and was admitted in respiratory failure and
cardiogenic shock, with multiple organ dysfunctions. Echocardiography
showed a left ventricle ejection fraction of 11%, severe diffuse
hypokinesia, and a systolic pulmonary artery pressure of 50mmHg, resulting
in the need for hemodynamic support with dobutamine (20mcg/kg/min) and
noradrenaline (1.7mcg/kg/min). After 48 hours with no clinical or
hemodynamic improvement, an extracorporeal membrane oxygenation was
implanted. The patient presented with hemodynamic, systemic perfusion and
renal and liver function improvements; however, his cardiac function did
not recover after 72 hours, and he was transfer to another hospital. Air
transport was conducted from Salvador to Recife in Brazil. A heart
transplant was performed with rapid recovery of both liver and kidney
functions, as well as good graft function. Histopathology of the explanted
heart showed chronic active myocarditis and amastigotes of
<italic>Trypanosoma cruzi</italic>. The estimated global prevalence of
<italic>T. cruzi</italic> infections declined from 18 million in 1991,
when the first regional control initiative began, to 5.7 million in 2010.
Myocarditis is an inflammatory disease due to infectious or non-infectious
conditions. Clinical manifestation is variable, ranging from subclinical
presentation to refractory heart failure and cardiogenic shock. Several
reports suggest that the use of extracorporeal membrane oxygenation in
patients presenting with severe refractory myocarditis is a potential
bridging therapy to heart transplant when there is no spontaneous recovery
of ventricular function. In a 6-month follow-up outpatient consult, the
patient presented well and was asymptomatic.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Jovem com 17 anos de idade atendido com dispneia progressiva h&#xE1; 15
dias e piora nas &#xFA;ltimas 24 horas. Foi admitido em estado de
insufici&#xEA;ncia respirat&#xF3;ria e choque cardiog&#xEA;nico com
disfun&#xE7;&#xE3;o de m&#xFA;ltiplos &#xF3;rg&#xE3;os. O
ecocardiograma mostrou fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o
ventricular esquerda de 11%, grave hipocinesia difusa e press&#xE3;o
sist&#xF3;lica da art&#xE9;ria pulmonar de 50mmHg. Houve necessidade de
suporte hemodin&#xE2;mico com uso de dobutamina (20mcg/kg/minuto) e
noradrenalina (1,7mcg/kg/minuto). Ap&#xF3;s 48 horas, o paciente
n&#xE3;o apresentou melhora hemodin&#xE2;mica nem cl&#xED;nica,
optando-se, ent&#xE3;o, pela implanta&#xE7;&#xE3;o de membrana de
oxigena&#xE7;&#xE3;o extracorp&#xF3;rea. Ocorreu melhora do ponto de
vista hemodin&#xE2;mico, da perfus&#xE3;o sist&#xEA;mica, da
fun&#xE7;&#xE3;o renal e hep&#xE1;tica, por&#xE9;m, ap&#xF3;s 72
horas, n&#xE3;o houve recupera&#xE7;&#xE3;o da fun&#xE7;&#xE3;o
card&#xED;aca. Optou-se, assim, pela transfer&#xEA;ncia para outro
hospital. O paciente foi transferido por transporte a&#xE9;reo de
Salvador (BA) para Recife (PE). Foi realizado transplante card&#xED;aco
com r&#xE1;pida recupera&#xE7;&#xE3;o da fun&#xE7;&#xE3;o
hep&#xE1;tica e renal, e boa fun&#xE7;&#xE3;o do enxerto. A
histopatologia do cora&#xE7;&#xE3;o explantado demonstrou miocardite
cr&#xF4;nica ativa e amastigotas de <italic>Trypanosoma cruzi</italic>. A
preval&#xEA;ncia global estimada de infec&#xE7;&#xE3;o por <italic>T.
cruzi</italic> caiu de 18 milh&#xF5;es em 1991, quando a primeira
iniciativa regional de controle teve in&#xED;cio, para 5,7 milh&#xF5;es
em 2010. A miocardite &#xE9; uma doen&#xE7;a inflamat&#xF3;ria
causada por condi&#xE7;&#xF5;es infecciosas ou n&#xE3;o infecciosas.
As manifesta&#xE7;&#xF5;es cl&#xED;nicas variam desde um quadro
subcl&#xED;nico at&#xE9; insufici&#xEA;ncia card&#xED;aca e choque
cardiog&#xEA;nico. Diversos relatos sugerem que o uso de membrana de
oxigena&#xE7;&#xE3;o extracorp&#xF3;rea em pacientes com quadro grave
e refrat&#xE1;rio de miocardite &#xE9; uma op&#xE7;&#xE3;o como
terapia ponte at&#xE9; transplante card&#xED;aco, nos casos sem
recupera&#xE7;&#xE3;o espont&#xE2;nea da fun&#xE7;&#xE3;o
ventricular. Em uma consulta ambulatorial de acompanhamento realizada 6
meses ap&#xF3;s o transplante, o paciente encontrava-se bem e
assintom&#xE1;tico.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Extracorporeal membrane oxygenation</kwd>
        <kwd>Chagas cardiomyopathy</kwd>
        <kwd>Heart transplantation</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults can
be used as a bridge to myocardial recovery, cardiac transplantation or
implantation of a left ventricular assist device.<sup>(<xref rid="r1" ref-type="bibr">1</xref>)</sup></p>
      <p>There are two main types of ECMO: venovenous and venoarterial; venoarterial is the
method of choice for acute heart failure in adults.<sup>(<xref rid="r1" ref-type="bibr">1</xref>)</sup> The ECMO system, a modified heart-lung
machine, generally consists of a centrifugal pump, a heat exchanger and a
membrane oxygenator. Desaturated venous blood is aspirated from the right atrium
into a centrifugal pump through a long steel wire-reinforced cannula inserted
into the right atrium via the femoral vein. The pump outflow is directed into a
membrane oxygenator, and it is guided via an outflow cannula into the descending
aorta via the femoral artery.<sup>(<xref rid="r2" ref-type="bibr">2</xref>)</sup> Typical ECMO complications include systemic inflammatory
response syndrome, renal failure, limb ischemia and bleeding.<sup>(<xref rid="r2" ref-type="bibr">2</xref>)</sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 17-year-old Brazilian male presented with progressive dyspnea for 15 days,
worsening in the last 24 hours, and was admitted in respiratory failure and
cardiogenic shock, with multiple organ dysfunctions, to the cardiac intensive
care unit at the <italic>Hospital Ana Nery</italic>, Salvador-Brazil.
Echocardiography showed a left ventricle ejection fraction of 11%, severe
diffuse hypokinesia and a systolic pulmonary artery pressure of 50mmHg, which
resulted in the need for hemodynamic support with dobutamine (20mcg/kg/min) and
noradrenaline (1.7mcg/kg/min).</p>
      <p>After 36 hours with no clinical or hemodynamic improvement, peripheral
veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was implanted using
a centrifuge magnetic pump with a polymethylpentene oxygenation membrane
(Rotaflow Centrifugal Pump<sup>&#xAE;</sup>/Quadrox-i Adult/Bioline
coated/MAQUET Cardiopulmonary AG, Hirrlingen, Germany). Heparin treatment
(100UI/kg bolus and 20UI/Kg/h) was initiated. Blood flow was initially at
4.571mL/min, with 6.000mL/min gas flow (pure oxygen Sweeper). Hemodynamic
(noradrenaline dropped to 0.21mcg/kg/min), systemic perfusion (lactate of
17mmol/L dropped to 2.5mmol/L and increase diuresis volume), and renal (serum
creatinine from 3.5 to 1.2mg/dL) and liver (international normalized ratio 7.4
to 3.1) function improvement were evident in 24 hours (<xref ref-type="table" rid="t1">Table 1</xref>). After 36 hours, ventilator-associated pneumonia
was suspected (progressive infiltrate on chest radiograph, leukocytosis and
purulent tracheobronchial secretions), and teicoplanin and meropenem were
initiated. Within 72 hours of ECMO use, no cardiac function improvement was
noted and a transfer to the <italic>Instituto de Medicina Integral Professor
Fernando Figueira</italic> (IMIP) Transplant Center in Recife, Brazil was
then executed.</p>
      <table-wrap id="t1" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Clinical and hemodynamic parameters before and after extracorporeal
membrane oxygenation implantation<xref ref-type="table-fn" rid="TFN2">*</xref></p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">&#xA0;</th>
              <th rowspan="1" colspan="1">Before</th>
              <th rowspan="1" colspan="1">After</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Noradrenalin (mcg/kg/min)</td>
              <td align="center" rowspan="1" colspan="1">1.7</td>
              <td align="center" rowspan="1" colspan="1">0.2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Dobutamine (mcg/kg/min)</td>
              <td align="center" rowspan="1" colspan="1">20</td>
              <td align="center" rowspan="1" colspan="1">20</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mean blood pressure (mmHg)</td>
              <td align="center" rowspan="1" colspan="1">45</td>
              <td align="center" rowspan="1" colspan="1">66</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Heart rate (bpm)</td>
              <td align="center" rowspan="1" colspan="1">148</td>
              <td align="center" rowspan="1" colspan="1">110</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Lactate (mmol/L)</td>
              <td align="center" rowspan="1" colspan="1">17</td>
              <td align="center" rowspan="1" colspan="1">2.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Bicarbonate</td>
              <td align="center" rowspan="1" colspan="1">14</td>
              <td align="center" rowspan="1" colspan="1">21</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">pH</td>
              <td align="center" rowspan="1" colspan="1">7.28</td>
              <td align="center" rowspan="1" colspan="1">7.34</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Diuresis (mL/Kg/h)</td>
              <td align="center" rowspan="1" colspan="1">0</td>
              <td align="center" rowspan="1" colspan="1">1.4</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Serum creatinine (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">3.5</td>
              <td align="center" rowspan="1" colspan="1">2.1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">INR</td>
              <td align="center" rowspan="1" colspan="1">7.43</td>
              <td align="center" rowspan="1" colspan="1">3.21</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">AST</td>
              <td align="center" rowspan="1" colspan="1">7599</td>
              <td align="center" rowspan="1" colspan="1">3077</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">ALT</td>
              <td align="center" rowspan="1" colspan="1">6242</td>
              <td align="center" rowspan="1" colspan="1">4217</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Serum potassium (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">7.6</td>
              <td align="center" rowspan="1" colspan="1">4.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Ventilator FiO<sub>2</sub> (%)</td>
              <td align="center" rowspan="1" colspan="1">30</td>
              <td align="center" rowspan="1" colspan="1">21</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">pO<sub>2</sub>
</td>
              <td align="center" rowspan="1" colspan="1">114.8</td>
              <td align="center" rowspan="1" colspan="1">253</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PCO2</td>
              <td align="center" rowspan="1" colspan="1">35.3</td>
              <td align="center" rowspan="1" colspan="1">38</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SVO<sub>2</sub> (%)</td>
              <td align="center" rowspan="1" colspan="1">65</td>
              <td align="center" rowspan="1" colspan="1">72</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p>INR - international normalized ratio; AST - aspartate
aminotransferase; ALT - alanine aminotransferase; FiO<sub>2</sub>
- inspired oxygen fraction; SVO<sub>2</sub> - mixed venous oxygen
saturation.</p>
          </fn>
          <fn id="TFN2">
            <label>*</label>
            <p>Interval of 24 hours before and after implantation.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Air transport using a military plane was provided from Salvador to Recife 4 days
after admission (travelled distance of 675km) (<inline-supplementary-material xlink:href="rbti-27-04-0397-suppl01.pdf" mimetype="application" mime-subtype="pdf" id="d36e372" content-type="local-data">Figure 1S in electronic supplementary
material</inline-supplementary-material>). The logistics of inter-hospital
transport involved approximately 50 professionals from different specialties,
including physicians, nurses, physiotherapists, paramedics, perfusionists and
police officers due to the lack of a specialized team trained in ECMO transport
(<xref ref-type="fig" rid="f1">Figure 1</xref>). Heart transplant with
intraoperative ECMO decannulation was performed after 48 hours, with excellent
performance, rapid recovery of the liver and kidney functions, good graft
function and successful weaning off circulatory support. Histopathology of the
explanted heart showed chronic active myocarditis and amastigotes of
<italic>Trypanosoma cruzi</italic> (<xref ref-type="fig" rid="f2">Figure
2</xref>), presenting chagasic cardiomyopathy.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Logistics of inter-hospital transport between Salvador and Recife
(Brazil).</p>
            <p>ECMO - extracorporeal membrane oxygenation; SESAB -
<italic>Secretaria Estadual de Sa&#xFA;de da Bahia</italic>; SAMU
- <italic>Servi&#xE7;o M&#xF3;vel de Urg&#xEA;ncia</italic>; IMIP -
<italic>Instituto de Medicina Integral Professor Fernando
Figueira</italic>.</p>
          </caption>
          <graphic xlink:href="rbti-27-04-0397-g01"/>
        </fig>
      </p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Histology of an explanted heart sample. A) Photomicrograph (x400)
of an hematoxylin and eosin stained sample. B) At this
magnification (x1000), the organisms (amastigotes of
<italic>Trypanosoma cruzi</italic>) within a myocyte (arrow)
and the adjacent inflammatory response are more clearly
observed.</p>
          </caption>
          <graphic xlink:href="rbti-27-04-0397-g02"/>
        </fig>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The estimated global prevalence of <italic>T. cruzi</italic> infections declined
from 18 million in 1991, when the first regional control initiative began, to
5.7 million in 2010.<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup>
Myocarditis is an inflammatory disease due to infectious or non-infectious
conditions. Clinical manifestation is variable, ranging from subclinical
presentations to refractory heart failure and cardiogenic shock.<sup>(<xref rid="r4" ref-type="bibr">4</xref>)</sup> Mechanical circulatory
support with an intra-aortic balloon or ventricular assist devices should be
considered in cases refractory to medical therapy.<sup>(<xref rid="r4" ref-type="bibr">4</xref>)</sup> Several reports suggest that the use of ECMO
in patients presenting with severe refractory myocarditis is a potential
bridging therapy to heart transplantation when there is no spontaneous recovery
of ventricular function.<sup>(<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>)</sup> The VA-ECMO can be
percutaneously implanted at the bedside and can be kept for several weeks with
proper care. It is the preferred device when patients present with biventricular
dysfunction and often promotes rapid improvement of the hemodynamic status,
oxygenation parameters and organ function.<sup>(<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>)</sup> In the face
of heart function improvement, the mechanical support device can be
progressively withdrawn, but when cardiac function impairment is maintained, the
treatment of choice would be a long-term device or heart transplant.<sup>(<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>)</sup> In a 6-month follow-up outpatient consult, the
patient presented himself in good health, ratifying the cost-utility of this
procedure in Brazil.<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup></p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>In the presented case, veno-arterial extracorporeal membrane oxygenation was used
on a patient with multiple organ failure secondary to a defined and refractory
cardiogenic shock. The benefit of the method was unquestionable, even in the
advanced stages of renal and liver failure. The patient presented with a partial
recovery of the affected systems, making possible the implementation of the
definitive therapy to severe myocarditis or heart transplant. Long- and
short-distance inter-hospital transport on extracorporeal membrane oxygenation
can be safely performed, but it demands a subspecialized team, highly competent
in intensive care and be aware of the risks involved in transporting these
patients.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of interest:</bold> None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Responsible editor:</bold> Luciano C&#xE9;sar Pontes de Azevedo</p>
      </fn>
    </fn-group>
    <ack>
      <title>AGRADECIMENTOS</title>
      <p>We would like to thank the heart transplant team at the Instituto de Medicina
Integral Professor Fernando Figueira (IMIP) - PE, Christiane P&#xE1;dua
Arantes Freitas, An&#xED;sio Silva Freire Filho, Pompilio Sampaio Britto,
Servi&#xE7;o de Atendimento M&#xF3;vel (SAMU) - Salvador, Grupamento
A&#xE9;reo da Pol&#xED;cia Militar da Bahia (GRAER-PMBA), Central Estadual
de Regula&#xE7;&#xE3;o da Secretaria Estadual de Sa&#xFA;de da Bahia
(CER-SESAB) and Hospital Ana Nery.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>National Institute for Health and Care Excellence -
NICE</collab>
          </person-group>
          <source>Extracorporeal membrane oxygenation (ECMO) for acute heart failure
in adults</source>
          <month>3</month>
          <year>2014</year>
          <comment>Available in <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/ipg482/informationforpublic">https://www.nice.org.uk/guidance/ipg482/informationforpublic</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Werdan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gielen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ebelt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hochman</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Mechanical circulatory support in cardiogenic
shock</article-title>
          <source>Eur Heart J</source>
          <year>2014</year>
          <volume>35</volume>
          <issue>3</issue>
          <fpage>156</fpage>
          <lpage>167</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">24014384</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bern</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Chagas' disease</article-title>
          <source>N Engl J Med</source>
          <year>2015</year>
          <volume>373</volume>
          <issue>5</issue>
          <fpage>456</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="pmid">26222561</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montera</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Colafranceschi</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>AC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Rabischoffsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ianni</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Mady</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Bocchi</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Saad</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Braga</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ramires</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Bacal</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Feitosa</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Figueira</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>JD</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>Moura</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Campos</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Bittencourt</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Barbosa Mde</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moreira Mda</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Higuchi Mde</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schwartzmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Mangini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Bordignon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Salles</surname>
              <given-names>VA</given-names>
            </name>
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title>I Brazilian guidelines on myocarditis and
pericarditis</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2013</year>
          <volume>100</volume>
          <issue>4</issue>
          <supplement>Suppl 1</supplement>
          <fpage>1</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">23765413</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kindermann</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Barth</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mahfoud</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ukena</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lenski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yilmaz</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Update on myocarditis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2012</year>
          <volume>59</volume>
          <issue>9</issue>
          <fpage>779</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="pmid">22361396</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atluri</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ullery</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>MacArthur</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Goldstone</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Fairman</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Hiesinger</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rapid onset of fulminant myocarditis portends a favourable
prognosis and the ability to bridge mechanical circulatory support to
recovery</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>2013</year>
          <volume>43</volume>
          <issue>2</issue>
          <fpage>379</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="pmid">22564805</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Spanier</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Marelli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Flannery</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Tector</surname>
              <given-names>KA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improved survival in patients with acute myocarditis using
external pulsatile mechanical ventricular assistance</article-title>
          <source>J Heart Lung Transplant</source>
          <year>1999</year>
          <volume>18</volume>
          <issue>4</issue>
          <fpage>351</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="pmid">10226900</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sayer</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Parks</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Heart rescue: the role of mechanical circulatory support in
the management of severe refractory cardiogenic shock</article-title>
          <source>Curr Opin Crit Care</source>
          <year>2012</year>
          <volume>18</volume>
          <issue>5</issue>
          <fpage>409</fpage>
          <lpage>416</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">22895213</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bassi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Maciel</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Vasconcelos</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>CB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Uso de suporte hemodin&#xE2;mico e respirat&#xF3;rio por
meio de oxigena&#xE7;&#xE3;o extracorp&#xF3;rea por membrana
(ECMO) venoarterial em um paciente politraumatizado</article-title>
          <source>Rev Bras Ter Intensiva</source>
          <year>2011</year>
          <volume>23</volume>
          <issue>3</issue>
          <fpage>374</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">23949411</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mendes</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Zampieri</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Antoniali</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Caneo</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>da Cruz</surname>
              <given-names>LM</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Trindade</surname>
              <given-names>EM</given-names>
            </name>
            <collab>ERICC research group</collab>
            <collab>ECMO group Hospital S&#xED;rio Liban&#xEA;s and Hospital
das Cl&#xED;nicas de S&#xE3;o Paulo</collab>
          </person-group>
          <article-title>The economic effect of extracorporeal membrane oxygenation
to support adults with severe respiratory failure in Brazil: a
hypothetical analysis</article-title>
          <source>Rev Bras Ter Intensiva</source>
          <year>2014</year>
          <volume>26</volume>
          <issue>3</issue>
          <fpage>253</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">25295819</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
